MTS Health Partners LP
Dr. Ravi Mehrotra joined MTS Health Partners, L.P. as a partner in 2016 focusing on the life sciences space. Dr. Mehrotra brings nearly two decades of healthcare equity research experience to the strategic advisory and capital raising platform at MTS. Prior to joining MTS, Dr. Mehrotra led several equity research franchises and has been involved in over 200 IPOs and financings. Dr. Mehrotra spent 11 years at Credit Suisse, most recently as Global Head of Biotechnology Equity Research based in New York. Previous to which, he served as Head of European Biotechnology and EMEA Generics Equity Research in London. Dr. Mehrotra’s research was particularly focused on macro strategic and micro therapeutic analysis. During his time at Credit Suisse Dr. Mehrotra was ranked the number one biotechnology analyst in both Institutional Investor and Extel surveys for multiple years. Prior to Credit Suisse Dr. Mehrotra was Head of European Biotechnology Equity Research at SG Cowen and an Pharmaceuticals Equity Analyst at Deutsche Bank. Dr. Mehrotra holds a Bachelor of Science and a Ph.D. in Biochemistry from Manchester University, UK.